The levels of PGE2 in tumor tissues depend on the relative rates of PTGS2 (COX-2)/PGE synthase-dependent biosynthesis and hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD, also called as 15-PGDH)-dependent degradation. The gene discussed is PTGS2; the disease is neoplasm.